HSE approves ‘life-changing’ drug for children with spinal disease

  • 📰 IrishTimes
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 98%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Price of one-time infusion of Zolgensma that can cost $2.1m will now be reimbursed

The therapy is administered only once and alters the genetic barriers to normal muscle and nerve development that occur in a child with SMA.

Minister for Health Stephen Donnelly said the reimbursement of Zolgensma by the HSE represents a “great achievement” which will be welcomed by the families and carers of SMA patients. Prof Hennessy said she hoped this marked the beginning of an era that would ensure Irish patients had access to the most innovative and life-changing treatments available anywhere in the world.

The director of the patient representative group SMA Ireland, Jonathan O’Grady, said the agreement brought about a “hugely significant day” for Irish babies with the condition.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Garda probe launched into HSE contractor hackA Garda probe has been launched into the hacking of a Health Service Executive contractor, which resulted in the contact details of more than 1,000 service users being compromised. Cyberattack HSE
Source: IrishMirror - 🏆 4. / 98 Read more »